Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

Vitamin D supplementation consistently increased serum 25(OH)D concentrations across trials.

Source: Abstract. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Systematic review.

Systematic review

Uses explicit methods to identify, assess and summarise research on a defined question.

Meta-analysis unclear · Blinding not applicable to this review · Research setting awaiting verification

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Effect of vitamin D supplementation on metabolic syndrome parameters in adults: a systematic review of randomized controlled trials exploring the role of baseline vitamin D status and supplementation dose

Source: Article title.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Effect of vitamin D supplementation on metabolic syndrome parameters in adults: a systematic review of randomized controlled trials exploring the role of baseline vitamin D status and supplementation dose

Systematic review · Frontiers in Nutrition · 2026

Original publication title

Effect of vitamin D supplementation on metabolic syndrome parameters in adults: a systematic review of randomized controlled trials exploring the role of baseline vitamin D status and supplementation dose

Hind Alzarooni; Falak Zeb; Dimitrios Papandreou

Copyright © 2026 Alzarooni, Zeb and Papandreou.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

Vitamin D supplementation shows slight benefit for specific MetS components, particularly among vitamin D-deficient adults, but effects were inconsistent across trials and metabolic parameters. Substantial variability in study design, dosing strategies, and population characteristics limits definitive conclusions. Adequately powered, standardized randomized trials are needed to clarify vitamin D's role in metabolic syndrome management.

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

Metabolic syndrome (MetS) is a cluster of cardiometabolic abnormalities including central obesity, dysglycemia, hypertension, and dyslipidemia. Vitamin D deficiency is highly prevalent among adults with MetS and may contribute to insulin resistance, inflammation, and adverse lipid profiles. Although vitamin D supplementation has been reported to improve MetS parameters, limited information is available on whether these effects differ by baseline vitamin D status or supplementation dose, information essential for clinical decision-making.

Source: Introduction

Abstract: What methods does the paper describe?

This systematic review evaluated the effect of oral vitamin D supplementation on MetS components in adults and examined whether treatment effects appeared differ according to baseline vitamin D status and supplementation dose. A comprehensive search of PubMed/MEDLINE, Embase, Web of Science, and CENTRAL was conducted following PRISMA guidelines. Given the anticipated clinical and methodological heterogeneity across eligible trials, a narrative synthesis rather than meta-analysis was planned a priori. Risk of bias was assessed using the Cochrane Collaboration Risk of Bias Tool.

Eligible RCTs included those evaluating oral vitamin D supplementation for at least 8 weeks in adults diagnosed with metabolic syndrome or presenting at least 3 of 5 MetS components. In addition, comparator groups included placebo or dietary-instruction-only controls. Outcomes of interest included waist circumference, triglycerides, HDL-cholesterol, blood pressure, fasting glucose, homeostatic model assessment of insulin resistance (HOMA-IR), glycated hemoglobin (HbA1c), and body mass index (BMI).

Source: Methods

Abstract: Systematic review registration

Abstract: Results

Eight randomized controlled trials (634 participants) met the full eligibility criteria and were included in the narrative synthesis. Vitamin D supplementation consistently increased serum 25(OH)D concentrations across trials. Significant improvements were reported in triglycerides and insulin resistance indices in a subset of trials, and in selected inflammatory markers, waist circumference, and BMI in individual studies, while blood pressure, HDL-cholesterol, and fasting glucose showed no consistent change across the majority of trials. Findings were most favorable among participants with baseline vitamin D deficiency and in trials using higher supplementation doses, although these patterns are exploratory, as no trial was powered for formal subgroup comparison.

Risk-of-bias assessment indicated that seven of the eight evaluated trials had some concerns or high risk of bias in at least one domain, limiting the overall certainty of the evidence.

Source: Results

Abstract: Conclusions

Vitamin D supplementation shows slight benefit for specific MetS components, particularly among vitamin D-deficient adults, but effects were inconsistent across trials and metabolic parameters. Substantial variability in study design, dosing strategies, and population characteristics limits definitive conclusions. Adequately powered, standardized randomized trials are needed to clarify vitamin D's role in metabolic syndrome management.

Source: Conclusions
Authors’ abstract

Introduction

Metabolic syndrome (MetS) is a cluster of cardiometabolic abnormalities including central obesity, dysglycemia, hypertension, and dyslipidemia. Vitamin D deficiency is highly prevalent among adults with MetS and may contribute to insulin resistance, inflammation, and adverse lipid profiles. Although vitamin D supplementation has been reported to improve MetS parameters, limited information is available on whether these effects differ by baseline vitamin D status or supplementation dose, information essential for clinical decision-making.

Methods

This systematic review evaluated the effect of oral vitamin D supplementation on MetS components in adults and examined whether treatment effects appeared differ according to baseline vitamin D status and supplementation dose. A comprehensive search of PubMed/MEDLINE, Embase, Web of Science, and CENTRAL was conducted following PRISMA guidelines. Given the anticipated clinical and methodological heterogeneity across eligible trials, a narrative synthesis rather than meta-analysis was planned a priori. Risk of bias was assessed using the Cochrane Collaboration Risk of Bias Tool.

Eligible RCTs included those evaluating oral vitamin D supplementation for at least 8 weeks in adults diagnosed with metabolic syndrome or presenting at least 3 of 5 MetS components. In addition, comparator groups included placebo or dietary-instruction-only controls. Outcomes of interest included waist circumference, triglycerides, HDL-cholesterol, blood pressure, fasting glucose, homeostatic model assessment of insulin resistance (HOMA-IR), glycated hemoglobin (HbA1c), and body mass index (BMI).

Results

Eight randomized controlled trials (634 participants) met the full eligibility criteria and were included in the narrative synthesis. Vitamin D supplementation consistently increased serum 25(OH)D concentrations across trials. Significant improvements were reported in triglycerides and insulin resistance indices in a subset of trials, and in selected inflammatory markers, waist circumference, and BMI in individual studies, while blood pressure, HDL-cholesterol, and fasting glucose showed no consistent change across the majority of trials. Findings were most favorable among participants with baseline vitamin D deficiency and in trials using higher supplementation doses, although these patterns are exploratory, as no trial was powered for formal subgroup comparison.

Risk-of-bias assessment indicated that seven of the eight evaluated trials had some concerns or high risk of bias in at least one domain, limiting the overall certainty of the evidence.

Conclusions

Vitamin D supplementation shows slight benefit for specific MetS components, particularly among vitamin D-deficient adults, but effects were inconsistent across trials and metabolic parameters. Substantial variability in study design, dosing strategies, and population characteristics limits definitive conclusions. Adequately powered, standardized randomized trials are needed to clarify vitamin D's role in metabolic syndrome management.

Systematic review registration

CRD420261421121.

Publication and source details

Original title: Effect of vitamin D supplementation on metabolic syndrome parameters in adults: a systematic review of randomized controlled trials exploring the role of baseline vitamin D status and supplementation dose

Hind Alzarooni; Falak Zeb; Dimitrios Papandreou

Frontiers in Nutrition · 2026

* Correspondence: Dimitrios Papandreou, dpapandreou@sharjah.ac.aeCopyright © 2026 Alzarooni, Zeb and Papandreou.2026Alzarooni, Zeb and Papandreouhttps://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.The author(s) declared that financial support was not received for this work and/or its publication.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-12T07:48:10.267662+00:00

DOI: 10.3389/fnut.2026.1974621 · PMC13748253